Press/Media
- 175 - 200 out of 337 results
Search results
-
Insulin resistance contributes to racial disparities in breast cancer prognosis in US women
12/05/20
1 item of Media coverage
Press/Media
-
Insulin Resistance Contributes to Racial Disparities in Breast Cancer...
12/05/20
6 items of Media coverage
Press/Media
-
Insulin Resistance Contributes to Racial Disparities in Breast...
12/05/20
1 item of Media coverage
Press/Media
-
Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal.
12/05/20
1 item of Media coverage
Press/Media
-
Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal
12/05/20
1 item of Media coverage
Press/Media
-
Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal
12/05/20
1 item of Media coverage
Press/Media
-
Does Insulin Resistance Worsen Breast Cancer Prognosis in Black Women?
Nina Bickell & Emily Gallagher
12/05/20
1 item of Media coverage
Press/Media
-
Insulin Resistance Contributes to Racial Disparities in Breast Cancer Prognosis in U.S. Women, Mount Sinai Researchers Reveal
12/05/20
1 item of Media coverage
Press/Media
-
MESOBLAST LIMITED : - First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
Alan Moskowitz, Emilia Bagiella & Annetine Gelijns
7/05/20
2 items of Media coverage
Press/Media
-
First patients dosed in Mesoblast COVID-19 trial
Alan Moskowitz, Emilia Bagiella & Annetine Gelijns
7/05/20
1 item of Media coverage
Press/Media
-
First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome
Alan Moskowitz, Emilia Bagiella & Annetine Gelijns
6/05/20
1 item of Media coverage
Press/Media
-
MESOBLAST : First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS
Alan Moskowitz, Emilia Bagiella & Annetine Gelijns
6/05/20
1 item of Media coverage
Press/Media
-
First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast’s Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome
Alan Moskowitz, Emilia Bagiella & Annetine Gelijns
5/05/20 → 6/05/20
22 items of Media coverage
Press/Media
-
First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast’s Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome
Alan Moskowitz, Emilia Bagiella & Annetine Gelijns
6/05/20
1 item of Media coverage
Press/Media
-
Neighborhood racial and economic polarization and severe maternal morbidity
4/05/20
1 item of Media coverage
Press/Media
-
Mount Sinai Health System Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients
Alan Moskowitz, Emilia Bagiella, Keren Osman, John Levine & Annetine Gelijns
10/04/20
1 item of Media coverage
Press/Media
-
Mount Sinai Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients
Alan Moskowitz, John Levine, Emilia Bagiella, Keren Osman & Annetine Gelijns
10/04/20
1 item of Media coverage
Press/Media
-
Mount Sinai Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients
Alan Moskowitz, Emilia Bagiella, Keren Osman, John Levine & Annetine Gelijns
10/04/20
2 items of Media coverage
Press/Media
-
OTTY Honoree 2020 Dr. Carol Horowitz: Healing from Within; How Dr. Carol Horowitz is breaking down barriers to help more patients — and doctors — thrive
2/03/20
1 item of Media coverage
Press/Media
-
Mount Sinai Helps Liberia Build Its Sole Pathology Lab
Ann Marie Beddoe
25/02/20
1 item of Media coverage
Press/Media
-
Mount Sinai Helps Liberia Build Its Sole Pathology Lab
Ann Marie Beddoe
25/02/20
1 item of Media coverage
Press/Media
-
-
In the Community: BYC Blue wins Aston A.A. fourth-grade tournament
24/02/20
1 item of Media coverage
Press/Media